Fibroblast growth factor 2 (FGF-2) contributes to the EMT induction in transformed epithelial cells as a downstream effector of HOXB7, a homeodomain protein which is overexpressed in breast cancer (Wu et al., 2006). Here, FGF2 is linked to breast carcinoma.